Macrovascular disease and systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 59, Issue 1, 2000, Pages 39-43

  Ho, Meilien ^a   Veale, Douglas ^a   Eastmond, Clifford ^b   Nuki, George ^c   Belch, Jill ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CAROTID ARTERY DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; CAROTID ARTERY DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RISK FACTORS; SCLERODERMA, SYSTEMIC; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 0034082712     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.1.39     Document Type: Article

References (36)

1. 1 Belch JJF, Zoma A, Richards, Forbes CD, Sturrock RD. Vascular Damage and factor VIII related antigen in the rheumatoid diseases. Rheumatol Int 1987;7:107-11.
2. 2 Larkin JG, Belch JJF, Flannigan P, Forbes CD, Frier BM. Microvascular disease and limited joint mobility in diabetes. A comparision of fibrinolysis and and prostacyclin in diabetes and systemic sclerosis. Diabetic Med 1988;5: 53-6.
3. 3 Lau CS, McLaren M, Belch JJF. Factor VIII von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's phenomenon. Br J Rheumatol 1991;30:433-6.
4. 4 Lau CS, McLaren M, Mackay I, Belch JJF. Baseline plasma fibinolysis and its correlation with clinical manifestations in patients with Raynaud's Phenomenon Ann Rheum Dis 1993;52:443-8.
5. 5 Lau CS, O'Dowd A, Belch JJF. White blood cell activation in Raynaud's phenomenon of systemic sclerosis and VWF syndrome. Ann Rheum Dis 1992;51:249-52.
6. 6 Galt SW, McDaniel MD, Ault KA, Mitchell J, Cronenwett JL. Flow cytometric assessment of platelet function in patients with peripheral arterial occlussive disease. J Vasc Surg 1991;14:747 55.
7. 7 Bryan C, Howard Y, Brennan P, Black C, Silman A. Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol 1996;35:1122-6.
8. 8 Veale DJ, Collidge TA, Belch JJF. Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis 1995;54:853-5.
9. 9 Fowkes FGR, Housley E, Cawood EHH, MacIntyre CCA, Ruckley CV, Prescott RJ. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-92.
10. 10 Stafford L, Englert H, Gover J, Bertouch J. Distribution of macrovascular disease in scleroderma. Ann Rheum Dis 1998;57:476-9.
11. 11 Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-90.
12. 12 Faris I, McCollum P, Mantese V, Lusby R. Investigation of the patient with atheroma. In: Bell PRS, Jamieson CW, Ruckley CV, eds. Surgical management of vascular disease. London: WB Saunders, 1992:131-96.
13. 13 Walker WF, Spence VA and McCollum PT. Systolic pressure measurements in the ischaemic lower limb. Hospital Update 1986:343-58.
14. 14 McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991;87:118-28.
15. 15 Bernstein EF, Fronek A. Current status of non-invasive tests in the diagnosis of peripheral arterial disease. Surg Clin North Am 1982;62:473-87.
16. 16 National Cholesterol Education Program. Detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). National Institutes of Health. NIH Pub 1993;93:3095.
17. 17 Roederer GO, Langlois YE, Lusiani L, Jager KA, Primozich JF, Lawrence RJ, et al. The natural history carotid arterial disease in asymptomatic patients with cervical bruits. Stroke 1984;15:605-13.
18. 18 Johnson BF, Verlato F, Bergelin RO, Primozich JF, Strandness E Jr. Clinical outcome in patients with mild to moderate carotid artery stenosis. J Vasc Surg 1995;21:120-6.
19. 19 Laing S, Greenhalgh RM. The detection and progression of asymptomatic peripheral arterial disease. Br J Surg 1983;70:628-30.
20. 20 D'Angelo W, Fries JF, Masi AT, Schulman LE. Pathologic observations in sysyemic sclerosis (scleroderma). Am J Med 1969;46:428-39.
21. 21 Leinwald L, Duryea AW, Richter MN. Scleroderma (based on a study of over 150 cases). Ann Intern Med 1954;41:1003.
22. 22 Goetz RH. The pathology of progressive systemic sclerosis-(generalised scleroderma) J Capetown Postgrad Med Ass 1945;4:337-02.
23. 23 Antonovych TJ, Steingaszner LC. Pathologic changes in progressive systemic sclerosis. Georgetown Med Bull 1962;16:27.
24. 24 Ross R. The pathogenesis of atherosclerosis:a perspective for the 1990s. Nature 1993;362:801-9.
25. 25 Masuda J, Ross R. Atherogenesis during low level hypercholesterolaemia in the non-human primate.I. Fatty streak formation. Arteriosclerosis 1990;10:164-77.
26. 26 Masuda J, Ross R. Atherogenesis during low level hypercholesterolaemia in the nonhuman primate.II Fatty streak conversion to fibrous plaque. Arteriosclerosis 1990;10: 178-87.
27. 27 Belch JJF. The white blood cell as a risk factor for thrombotic vascular disease. Vascular Medicine Review 1990;1:203-13.
28. 28 Bruckdorfer R, Hillary JB, Bunce T, Vancheeswaran R, Black CM. Increased susceptibility to oxidation of low density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum 1995;38:1060-7.
29. 29 Leng GC, Fowkes FGR, Lee AJ, Dunbar J, Ruckley CV. Use of ankle-brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 1996;313:1440-4.
30. 30 Vogt MT, McKenna M, Anderson SJ, Wolfson SK, Kuller LH. The relationship between ankle-arm index and mortality in older men and women. J Am Geriatr Soc 1993;41:523-30.
31. 31 Vogt MT, Cauley JA, Kuller LH, Hulley SB. Decreased ankle/arm blood pressure index and mortality in women. JAMA 1993;240:465 9.
32. 32 Jacobsen S, Halberg P, Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 1998;37:750-5.
33. 33 Duprez D, Clement DL. Medical treatment of peripheral vascular disease: good or bad? Eur Heart J 1992;13:149-51.
34. 34 APT Collaboration, Clinical Trial Service Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford. BMJ 1988;296:320-31.
35. 35 Torres MA, Furst DE. Treatment of systemic sclerosis. Rheum Dis Clin North Am 1990;16:217-41.
36. 36 CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.